Skip to contentHit to Lead
Selected hits to design potent and selective analogs.
We refine selected hits to design potent and selective analogs. To reduce the attrition rate, we use a combination of comprehensive drug discovery capabilities (structure-based drug design, chemoinformatics, biology and biophysical platforms) focusing on physicochemical properties to design druggable compounds.
For active compounds, we study in vitro ADME data (e.g. solubility, permeability, stability) and pharmacokinetic parameters. Front-loading enables preliminary structure-activity relationship to be built in order to identify the best candidates for lead optimization.
Want more information?
We are ready to support your projects
COOKIES
NovAliX place cookies on your terminal cookies from the novalix.com site, to improve your navigation experience and analyze traffic.
This page allows you to give or withdraw your consent for the use of cookies on the novalix.com site either globally (by clicking on the "Accept all" or "Reject all" button), or on a purpose-by-purpose basis (by clicking on the "Personalize my choices" button). These cookies are only placed if you give your consent.
We retain your choice for 6 months. For further information, please consult our cookie policy
Manage cookies consent
Novalix is changing the future of drug discovery with a fresh new look.
The new website is currently
under construction.